Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bevacizumab (avastin) (1 trial)
durvalumab (imfinzi) (1 trial)
Glioblastoma (Phase 2)
Trials (1 total)
Trial APIs (2 total)